A potential explanation for these findings could involve the ability of regulatory T cells to control the IL-17-dominated inflammatory response [27], but studies should be conducted to determine if there is an association between IL-17 gene expression and a reduced or raised regulatory T cell function in the PBMCs of post-COVID-19 patients with normal and abnormal spirometry. The gene discussed is IL17A; the disease is COVID-19.